4//SEC Filing
GRANNER DARYL K 4
Accession 0001127602-09-002736
CIK 0000729922other
Filed
Feb 4, 7:00 PM ET
Accepted
Feb 5, 7:15 PM ET
Size
12.9 KB
Accession
0001127602-09-002736
Insider Transaction Report
Form 4
GRANNER DARYL K
Director
Transactions
- Exercise/Conversion
Stock Option (Right to Buy)
2009-02-03−7,500→ 2,500 totalExercise: $15.02From: 2004-03-19Exp: 2013-03-18→ Common Stock (7,500 underlying) - Exercise/Conversion
Common Stock
2009-02-03$15.02/sh+7,500$112,650→ 26,537 total - Exercise/Conversion
Stock Option (Right to Buy)
2009-02-03−2,500→ 0 totalExercise: $20.31From: 2001-03-15Exp: 2010-03-15→ Common Stock (2,500 underlying) - Exercise/Conversion
Common Stock
2009-02-03$20.31/sh+2,500$50,783→ 19,037 total - Sale
Common Stock
2009-02-03$42.10/sh−10,000$420,954→ 16,537 total
Footnotes (4)
- [F1]Transaction made pursuant to a 10b5-1 plan dated March 3, 2008.
- [F2]The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $42.00 to $42.76 per share. The Reporting Person will provide upon request of the staff of the U.S. Securities and Exchange Commission, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- [F3]One third of the stock option became exercisable one year after the date of the grant and the remainder vested ratably on a monthly basis over the succeeding 24 months.
- [F4]Includes only options with the same termination date.
Documents
Issuer
OSI PHARMACEUTICALS INC
CIK 0000729922
Entity typeother
Related Parties
1- filerCIK 0001238974
Filing Metadata
- Form type
- 4
- Filed
- Feb 4, 7:00 PM ET
- Accepted
- Feb 5, 7:15 PM ET
- Size
- 12.9 KB